Please login to the form below

Not currently logged in
Email:
Password:

Serge Bernasconi appointed CEO of Eucomed and EDMA ahead of alliance

Joins from Medtronic to lead trade bodies’ efforts to speak as “one voice”

Serge Bernasconi - Eucomed EDMASerge Bernasconi (pictured) is to become the first CEO of both Eucomed and the European Diagnostic Manufacturers Association (EDMA) as the two trade organisations attempt to combine efforts under an alliance.

Former Medtronic VP, Bernasconi, will take over from interim Eucomed CEO Luciano Cattani and EDMA CEO Volker Oeding on July 16, 2012, leading efforts from both groups to speak with “one voice” to address issues of mutual interest.

“The time is right to further intensify the cooperation between Eucomed and EDMA,” Eucomed chair Dr Guy Lebeau. “With his experience and strengths, Serge brings a unique mix of skills to the table which make him uniquely positioned to oversee this process and continue the successful journey both associations have taken.”

Bernasconi has more than 30 years' experience in both the pharmaceutical and medical device industries, serving most recently as president and international regional VP of Medtronic France.

During this time, he gained understanding as an industry representative having been elected president of the French Association for the Promotion of Innovation in Medical Devices (APIDIM), and VP and treasurer of French Medical Technology Industry Association (SNITEM).

In addition, he has worked at Johnson & Johnson (J&J) and Schering Plough in both the US and Europe.

Bernasconi said: “I am excited to become part of a team committed to driving value-based innovation in the industry and as such contributing to more sustainable healthcare systems. I am convinced that both associations occupy an excellent position to help in advancing healthcare in Europe.”

11th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics